The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs) that have become dominant as the pandemic progresses bear the ORF8 mutation together with multiple spike mutations. A 382-nucleotide deletion (Δ382) in the ORF7b and ORF8 regions has been associated with milder disease phenotype and less systemic inflammation in COVID-19 patients. However, its impact on host immunity against SARS-CoV-2 remains undefined. Here, RNA-sequencing was performed to elucidate whole blood transcriptomic profiles and identify contrasting immune signatures between patients infected with either wildtype or Δ382 SARS-CoV-2 variant. Interestingly, the immune landscape of Δ382 SARS-CoV-2 infected patients featured an increased adaptive immune response, evidenced by enrichment of genes related to T cell functionality, a more robust SARS-CoV-2-specific T cell immunity, as well as a more rapid antibody response. At the molecular level, eukaryotic initiation factor 2 signaling was found to be upregulated in patients bearing Δ382, and its associated genes were correlated with systemic levels of T cell-associated and pro-inflammatory cytokines. This study provides more in-depth insight into the host–pathogen interactions of ORF8 with great promise as a therapeutic target to combat SARS-CoV-2 infection. Supplementary Information The online version contains supplementary material available at 10.1007/s10875-021-01142-z.
【저자키워드】 COVID-19, Transcriptome, SARS-CoV-2, Antibody Response, ORF8, Adaptive immune response, CD4+ T cell response, CD8+ T cell response, 【초록키워드】 coronavirus, Mutation, Cytokines, Immunity, SARS-COV-2 infection, SARS-CoV-2 variant, variants of concern, severe acute respiratory syndrome Coronavirus, immune, T cell, Region, ORF8, VOCs, Patient, pro-inflammatory cytokines, spike mutations, systemic inflammation, molecular, respiratory, RNA-sequencing, COVID-19 patients, ORF7b, Signaling, Host–pathogen interaction, therapeutic target, initiation factor, acute respiratory syndrome, supplementary material, acute respiratory syndrome coronavirus, acute respiratory syndrome coronavirus 2, profile, enrichment, host immunity, Δ382, wildtype, disease phenotype, systemic level, eukaryotic initiation factor 2, nucleotide deletion, dominant, robust, immune signature, identify, was performed, provide, less, correlated, upregulated, evidenced, eukaryotic, pandemic progresse, SARS-CoV-2 infected patient, whole blood transcriptomic,